< Back to latest news & events

Event

Translational Microbiome Conference 2020

April 2020

Event date: 24th April 2020

Translational Microbiome Conference 2020 will be hosted on 21-24 April. It will bring together the leading microbiome companies working to successfully commercialise microbiome-based diagnostics, therapeutics, adjunct therapies and direct-to-consumer services and products across a range of therapeutic areas, from gut to skin and beyond.

The conference will focus on the challenges and hurdles that companies working in the microbiome space will have to recognise and navigate in order to successfully commercialise their products.

HGF Partner Craig Thomson will be hosting a panel discussion:

Getting your bugs in a row: preparing your IP for investment

Intellectual Property (IP) is only one of the things that investors look at when deciding to invest. How important is IP to investors? What questions can you expect to be asked of your IP? We will also explore what can be done in advance to make it easier to clearly and efficiently demonstrate to investors that your IP adequately underpins the business seeking investment (and how this can be done when funds are tight). The panel will consist of investors, microbiome professionals that are experienced at obtaining large and small level investments, and those that have assisted investors to review IP portfolios as part of pre-investment due diligence.

Attendees

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

IP Ingredients: The not so "Impossible" Burger

Meat alternatives are a hot topic with the increase in popularity of vegetarianism and veganism, highlighted by this month being “veganuary”.  However, at time when meat alternatives are coming under …

Read article

WTR 1000 2025

We are proud to announce that our European trade mark team has been recognised in the World Trade Mark Review 1000 2025. The firm is also proud to have 19 …

Read article

Court of Appeal Confirms No Second Medical Use SPCs in UK

Merck Serono SA  v  The Comptroller-General of Patents, Designs, and Trade Marks – Lewison LJ, Arnold LJ and Birss LJ – [2025] EWCA Civ 45 – 28 January 2025 The …

Read article

T 0295/22: Apremilast decision highlights hopes and challenges for broad second medical use claims

This case provides insight to the EPO’s interpretation of administration features in second medical use claims. Whilst the door appears to be open for broader second medical use claims, they …

Read article

T 1418/22: Acalabrutinib provides guidance on establishing inventiveness of polymorphs at the EPO

The EPO Board of Appeal’s decision in T 1418/22 gives useful guidance on the inventiveness of polymorph claims in Europe. Starting from a known amorphous form, a specific crystalline form …

Read article

HGF Celebrates Two Nominations at the Women and Diversity in Law Awards

We are proud to share that we have been nominated for two awards at The Women and Diversity in Law Awards which will take place on 18th March at Hilton …

Read article